Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
13/10/2022

Archive: 13/10/2022

In major retreat, Bright Health halts individual health insurance coverage

Bright Health Group will end individual and family health insurance coverage and reduce its Medicare Advantage coverage to just two states, steps that will cut its revenue in half.

Oct 13, 2022

0

23

Understanding mental health and mental illness

Mental health is the overall wellness of how you think, regulate your feelings and behave. A mental disorder may be present when patterns or changes in thinking, feeling or behaving cause distress or disrupt a person's ability ...

Oct 13, 2022

0

5

Projecting a path for clinical translation of 3D-bioprinted human tissues

Three-dimensional bioprinting is an emerging technology that has the potential to build human tissue, on demand, to treat a wide range of human diseases. However, bridging the gap from research at the benchtop to clinical ...

Oct 13, 2022

0

57

Autism institute releases recommendations for autism and the criminal justice system

Autistic individuals interact with the justice system at high rates as both victims and offenders. Drexel University's A.J. Drexel Autism Institute explored ways to improve interactions between autistic individuals and the ...

Oct 13, 2022

0

4

New study finds distinct brain networks associated with risk and resilience in depression

A new study that links the location of brain injury to levels of depression in patients following the injury has identified two distinct brain networks; one associated with increased depression symptoms and one associated ...

Oct 13, 2022

0

40

Supporting caregivers of kids with developmental disorders: There's an app for that

A web-based app shows potential for advancing the communication skills of children with developmental disorders in low- and middle-income countries, according to a recent study co-authored by Georgia State University researchers.

Oct 13, 2022

0

11

CVS will lower price of menstrual products in many states with 'tampon tax'

CVS Health announced Wednesday that it will lower the prices of its brand of menstrual products by 25% in 12 states that tax tampons, pads and similar items.

Oct 13, 2022

0

9

FDA says ADHD med Adderall is in short supply

People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.

Oct 13, 2022

0

6

Survey shows majority of physicians favor allowing telehealth to treat opioid-use disorder

A survey of more than 1,000 registered physicians who used telehealth services to treat patients with opioid-use disorder during COVID-19 found that an overwhelming majority favor making telehealth a permanent part of their ...

Oct 13, 2022

0

0

FDA approves Boostrix for third-trimester administration

The U.S. Food and Drug Administration has approved Boostrix for immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.

Oct 13, 2022

0

2

page 3 from 9

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2025 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us